Showing results (71-80 of 122) with videos related to

Sort By:
Pageof 13
Oncotarget|January 1, 2017
Heterogeneity and frequency of BRAF mutations in primary melanoma: Comparison between molecular methods and immunohistochemistryWilliam Bruno, Claudia Martinuzzi, Virginia Andreotti, et al.
JCO Precision Oncology|February 24, 2022
Plasma Cell-Free DNA Integrity Assessed by Automated Electrophoresis Predicts the Achievement of Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients With Breast CancerGabriella Cirmena, Lorenzo Ferrando, Francesco Ravera, et al.
Blood|December 23, 2004
Evidence for a protective role of Mcl-1 in proteasome inhibitor-induced apoptosisAlessio Nencioni, Fei Hua, Christopher P Dillon, et al.
Targeted Oncology|October 25, 2014
Afatinib resistance in non-small cell lung cancer involves the PI3K/AKT and MAPK/ERK signalling pathways and epithelial-to-mesenchymal transitionSimona Coco, Anna Truini, Angela Alama, et al.
Current Cancer Drug Targets|January 22, 2010
Ras-induced resistance to lapatinib is overcome by MEK inhibitionGabriele Zoppoli, Eva Moran, Debora Soncini, et al.
European Journal of Clinical Investigation|July 11, 2020
Comprehensive geriatric assessment in older adults with cancer: Recommendations by the Italian Society of Geriatrics and Gerontology (SIGG)Domenico Fusco, Alessandro Ferrini, Giuseppe Pasqualetti, et al.
Journal of Oncology|May 8, 2020
Circulating Tumor DNA Using Tagged Targeted Deep Sequencing to Assess Minimal Residual Disease in Breast Cancer Patients Undergoing Neoadjuvant ChemotherapyGabriella Cirmena, Anna Garuti, Marilena De Mariano, et al.
British Journal of Pharmacology|January 28, 2017
5-fluorouracil causes endothelial cell senescence: potential protective role of glucagon-like peptide 1Paola Altieri, Roberto Murialdo, Chiara Barisione, et al.
Experimental Hematology|August 11, 2010
Potent synergistic interaction between the Nampt inhibitor APO866 and the apoptosis activator TRAIL in human leukemia cellsGabriele Zoppoli, Michele Cea, Debora Soncini, et al.
JCI Insight|September 22, 2021
SLFN11 captures cancer-immunity interactions associated with platinum sensitivity in high-grade serous ovarian cancerClaudia Winkler, Matthew King, Julie Berthe, et al.
Pageof 13